Skip to main content
Caplight Logo









InSphero

InSphero

Private
SchlierenHealthcare & Life Scienceshttps://insphero.com

Last Round

Series D

Mar 31, 2023

Total Funding Raised

$26.49M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

InSphero operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Series D round in March 2023.

InSphero is a biotechnology company that develops and provides 3D cell-based assay and organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

InSphero Comparables

Compare InSphero with similar companies based on industry and business-model similarity.

InSphero comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MIMETAS
88%
Emulate
86%
CN Bio
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

InSphero Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 31, 2023
GrantJan 23, 2023
VC RoundJun 13, 2018
Series CJul 8, 2015
Series BJun 18, 2013
Series A
Aug 5, 2010
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jan Lichtenberg

Chief Executive Officer And Board Member

Executive Team

For institutional investors. Book with your work email.

InSphero Investors

Notable investors and investment history

InSphero investors
InvestorRounds
Eurostars SME programmeGrant
InnosuisseGrant
RedalpineVC Round, Series A
BpifranceGrant
OCCIDENTSeries D
Zurcher KantonalbankVC Round, Series A
ZEISS VenturesSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Acquired Gri3D technology from Sun Bioscience.

  • Nov 12, 2025

    Acquired DOPPL SA.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • hiresAug 17, 2026

    InSphero AG promotes Dr. Olivier Frey from Vice President of Technologies and Platforms to Chief Operating Officer and Chief Technology Officer in Switzerland on Aug 17th '26, where he leads technology strategy, operational efficiency, digitalization, and automation.

  • promotesAug 17, 2026

    On Aug 17th '26, InSphero AG promotes Olivier Frey, previously Vice President of Technologies and Platforms, to Chief Operating Officer and Chief Technology Officer, where he leads technology strategy, operational efficiency, and automation.

Book a demo to see all news

For institutional investors. Book with your work email.

InSphero Filings

Explore SEC and related filing metadata, where available.

InSphero filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about InSphero's valuation, stock price, and market status.

Is InSphero a public or private company?

InSphero is a private company.

What is the current stock price of InSphero?

InSphero is a private company, so its shares have no public market price. Caplight tracks InSphero's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is InSphero worth (valuation)?

Valuation information for InSphero is not publicly available.

Can I buy InSphero stock?

InSphero shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was InSphero's last funding round?

InSphero's most recent funding round was Series D on March 31, 2023.

Who are the main investors in InSphero?

Key investors in InSphero include Redalpine, ZEISS Ventures.

Will InSphero IPO soon?

No public IPO plans have been announced for InSphero.

How can I track InSphero secondary market activity?

Caplight tracks bids, offers, and trades in InSphero's shares on secondary markets.

Firmographic Details

HeadquartersSchlieren
Employee Range75
Year Founded2009
Last FundingMar 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?